the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, Abergel A, Mangia A, Lai CL, Chan HL, Mazzotta F, Moreno C, Yoshida E, Shafran SD, Towner WJ, Tran TT, McNally J, Osinusi A, Svarovskaia E, Zhu Y, …
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection Read more »
February 26, 2016 – Two new treatments for oncologic indications have been approved by the American Food and Drug Administration (FDA). Thus, the FDA approved Obinutuzumab (Gazyva) for use in combination with bendamustine followed by Obinutuzumab (Gazyva) monotherapy for the treatment of patients with follicular …
News for Obinutuzumab (Gazyva) and Everolimus (Afinitor) Read more »
February 4, 2016 – This article is relied from FDA’s press release section and only very sightly edited. In response to the rampant opioid abuse epidemic in the United States (and very likely in other parts of the world too), Dr. …
February 07, 2016 – The European Commission has approved once-daily Osimertinib (Tagrissa) for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) that is positive for the epidermal growth-factor receptor (EGFR) T790M mutation. This follows a positive review in …
January 30, 2016 – Hepatitis C is a viral disease that causes inflammation of the liver that can lead to diminished liver function or liver failure. Most people infected with HCV have no symptoms of the disease until liver damage becomes …
January 28, 2016 – Soft tissue sarcoma (STS) is a disease in which cancer cells form in the soft tissues of the body, including the muscles, tendons, fat, blood vessels, lymph vessels, nerves and tissues around joints. Liposarcoma is a specific …
January 21, 2016 – This is a never ending story. The present notification by the The American Food and Drug Administration (FDA) is once more to inform the public of a growing trend of dietary supplements or conventional foods with hidden …
Wonder-Erect Male Pills: No wonder they contain hidden drug ingredient vardenafil Read more »
January 20, 2016 – The American Food and Drug Administration (FDA) just approved Ofatumumab (Arzerra) Injection for extended treatment of patients who are in complete or partial response after at least two lines of therapy for recurrent or progressive chronic lymphocytic leukemia (CLL). Ofatumumab, also …
December 24, 2015 – The American Food and Drug Administration (FDA) just approved Lesinurad (Zurampic) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a …
December 16, 2015 – This post is somewhat delayed; however, it may still be of interest for some readers of thasso post and therefore, the information is provided here uncommented, as it was issued by both the FDA and the EMA …